Insulin‐and insulin‐like growth‐factor‐I receptor tyrosine‐kinase activities in human renal carcinoma

International Journal of Cancer

Volumn 62, Issue 5, 1995, Pages 501-507

  Kellerer, Monika ^a   von Eye Corleta, Helena ^a   Mühlhöfer, Andreas ^a   Capp, Edison ^a   Mosthaf, Luitgard ^a   Bock, Susanne ^b   Petrides, Petro E ^b,c   Häring, Hans U ^a  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL;

CARCINOMA; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KIDNEY NEOPLASMS; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SUPPORT, NON-U.S. GOV'T;

EID: 0029161101     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910620502     Document Type: Article

References (39)

1. Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney
2. A novel fetal insulin‐like growth factor (IGF) I receptor. Mechanism for increased IGF‐I‐ and insulin‐stimulated tyrosine‐kinase activity in fetal muscle
3. Expression of insulin‐like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningip‐mas: in vivo studies using in situ hybridization and immunocytochemistry
4. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti‐mitogenic activity
5. Partition of insulin‐like growth‐factor(IGF)‐binding sites between the IGF‐I and IGF‐II receptors and IGF‐I binding proteins in human kidney
6. Expression of c‐sis/platelet‐derived‐growth‐factor‐B, insulin‐like‐growth‐factor‐I and transforming‐growth‐factor‐alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry
7. Comparison of insulin and IGF‐I receptors
8. Co‐stimulation of gastrointestinal tumour‐cell growth by gastrin, transforming growth factor alpha and insulin‐like growth factor‐I
9. Functional and immunological distinction between insulin‐like growth‐factor‐I‐receptor sub‐types in KB cells
10. Over‐expression of insulin receptors in fibroblast and ovary cells induces a ligand‐mediated transformed phenotype
11. Insulin and insulin‐like growth factor I in brain tumors: binding and in vitro effects
12. Tumor‐promoting phorbolesters increase the Km of the ATP‐binding site of the insulin receptor kinase from rat adipocytes
13. The insulin receptor: its role in insulin action and pathogenesis of insulin resistance
14. Tyrosine‐kinase activity in breast cancer, benign breast disease, and normal breast tissue
15. Effects of diabetes and sex‐steroid hormones on insulin receptor tyrosine‐kinase activity in R3230AC mammary adenocarcinomas
16. Characterization of human placental insulin‐like growth factor‐1/insulin hybrid receptors by protein micro‐sequencing and purification
17. Distinct alpha‐sub‐unit structures of human insulin receptor A and B variants determine differences in tyrosine‐kinase activities
18. An altered IGF‐I receptor is present in human leukemic cells
19. Insulin activates GTP binding to a 40‐kDa protein in fat cells
20. Insulin and insulin‐like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26
21. Different ligand affinities of the two human insulin‐receptor splice variants are reflected in parallel changes in sensitivity for insulin action
22. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC
23. Insulin‐receptor expression and function in human breast‐cancer cell lines
24. Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet‐derived growth factor and insulin‐like growth factor‐1
25. Functionally distinct insulin receptors generated by tissue‐specific alternative splicing
26. Insulin‐like growth‐factor‐I‐receptor beta‐sub‐unit heterogeneity. Evidence for hybrid tetramers composed of insulin‐like growth‐factor‐I and insulin receptor heterodimers
27. Insulin receptor expression in Burkitt‐lymphoma cell lines
28. Enhanced insulin receptor tyrosine‐kinase activity associated with chromosomal translocation (1;19) in a pre‐B‐cell leukemia line
29. Dephosphorylation of human insulin‐like growth‐factor‐I(IGF‐I) receptors by membrane‐associated tyrosine phosphatases
30. Alterations of gene expression as prognostic markers in adult renal carcinoma
31. The mitogenic activity of insulin: an intrinsic property of the molecule
32. The nucleotide and partial amino‐acid sequences of rat fetuin. Identity with the natural tyrosine‐kinase inhibitor of the rat insulin receptor
33. Production of inhibitor of insulin receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM
34. The attraction of proteins for small molecules and ions
35. Purified hybrid insulin/insulin‐like growth‐factor‐I receptors bind insulin‐like growth factor‐I, but not insulin, with high affinity
36. Immunological relationships between receptors for insulin and insulin‐like growth factor I. Evidence for structural heterogeneity of insulin‐like‐growth‐factor‐I receptors involving hybrids with insulin receptors
37. Receptors for insulin and insulin‐like growth factor‐I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells
38. The two isotypes of the human insulin receptor (HIR‐A and HIR‐B) follow different internalization kinetics
39. Functional properties of two naturally occurring is forms of the human insulin receptor in Chinese hamster ovary cells